Intriguingly, we observed slight but significant telltale increases in mPAP (i.e., RV afterload) and RV hypertrophy in CXCL12-treated mice, which are common indicators of PAH-like phenotypes. This evidence concerns the gene CXCL12 and pulmonary arterial hypertension.